NEW YORK — International infectious disease diagnostics organization FIND said last week that it has received a $10 million grant from the UK Department of Health and Social Care's Global AMR Innovation Fund (GAMRIF) to support the development and use of new diagnostics to combat antimicrobial resistance (AMR) in low-resource settings.
According to FIND, GAMRIF will contribute $10 million to the four-year effort, which will focus on developing and implementing rapid diagnostics and digital tools designed specifically for addressing AMR that can be used in primary care, community settings, and other places where people first access healthcare. A particular area of interest will be around common infectious that may or may not require antibiotic treatment such as sexually transmitted disease.
The funding will also be used for the development, evidence generation, and early implementation of novel AMR tests and digital tools that can help patients with severe infections receive the proper treatment early, FIND said. It will also help in the creation of open-access digital technologies to enable near real-time AMR surveillance systems based on routine, digitally connected diagnostic tools.
"AMR is a global threat, directly killing 1.25 million people across the world each year, with the highest burden in low- and middle-income countries," Sally Davies, UK special envoy on AMR, said in a statement. "These tests and digital tools will aid clinical decision-making, ensuring that patients get the most appropriate treatment when they need it, as well as improving data collection to enhance our understanding of AMR locally and globally."